A Previously Unrecognized Site of Resistance in POAG

POAG 中以前未被识别的耐药位点

基本信息

  • 批准号:
    7895602
  • 负责人:
  • 金额:
    $ 20.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The source of abnormal outflow resistance in primary open angle glaucoma (POAG), a leading cause of blindness, has yet to be identified. We have found that acute elevation of intraocular pressure (IOP) in normal bovine and human eyes causes a decrease in the available area for aqueous outflow, Schlemm's canal (SC) to collapse and reversible herniations into collector channel (CC) ostia. In contrast, herniations were commonly observed in human POAG eyes even at 0 mmHg, suggesting that a normally reversible process of hernia formation becomes irreversible in the diseased state. A number of herniated regions in POAG eyes appear denser and with local accumulation of extracellular matrix compared with the herniated regions following acute IOP elevation in normal eyes. We propose that as more irreversible herniations develop in the CC ostia, the outflow facility would progressively decrease and IOP would rise. Critical data supporting this hypothesis comes from clinical studies demonstrating that flow of fluorescein or trypan blue injected into SC of POAG eyes is blocked from entering the episcleral veins in certain regions. A poorer prognosis following a non- penetrating glaucoma surgery in POAG eyes seems to be associated with increased numbers of these blockages. Our goal is to determine whether the irreversible herniations in POAG eyes we have identified account for the blockage of the fluorescein or trypan blue egress from SC into episcleral veins observed clinically in POAG patients and the physiological significance of these findings in the pathogenesis of POAG and in the prognosis of non-penetrating glaucoma surgery. We hypothesize that the decreased outflow facility in POAG eyes is associated with a decrease in effective filtration area in the juxtacanalicular connective tissue and inner wall of SC, and is proportionally associated with an increased number of irreversible herniations into CC ostia. We hypothesize that these herniations are responsible for blocking the fluorescein or trypan blue from entering the episcleral veins from SC in clinical studies. To investigate this hypothesis three specific aims are proposed: 1. Distinguish the hydrodynamic and structural differences between the reversible herniations into CC ostia observed in normal human eyes with acute IOP elevation and irreversible herniations in POAG eyes. 2. Determine whether the blockage of trypan blue or fluorescein entering the episcleral veins from SC observed clinically is caused by irreversible herniations in glaucomatous eyes compared to normal eyes. This will be examined histologically by tracing nanoparticles through these herniated regions after in vivo injection in the naturally occurring and laser-induced glaucomatous monkey eyes. 3. Establish an egress pattern of dye from SC to episcleral veins as it appears in normal eyes, termed "channelography" and investigate its common changes in POAG patients undergoing a non-penetrating glaucoma surgery and its relationship to post- operative IOP reduction. If we can confirm that irreversible herniations into CC ostia are indeed the site blocking the aqueous outflow, a new site of added resistance in POAG will be identified. PUBLIC HEALTH RELEVANCE: Primary Open-angle Glaucoma is a major cause of permanent blindness, found in approximately 2% of individuals over the age of 40, and affects over 70 million people in the world. The goal of our research is to identify the pathologic factors contributing to elevated outflow resistance in primary open angle glaucoma.
描述(由申请人提供):原发性开角型青光眼(POAG)的异常外流阻力来源尚未确定,POAG是导致失明的主要原因。我们已经发现,在正常的牛和人类眼睛的眼内压(IOP)的急性升高导致减少的可用面积的水流出,Schlemm管(SC)崩溃和可逆的疝入收集通道(CC)口。相比之下,即使在0 mmHg下,在人POAG眼中也经常观察到疝,这表明正常可逆的疝形成过程在患病状态下变得不可逆。与正常眼急性眼压升高后的疝出区域相比,POAG眼的许多疝出区域出现更致密的细胞外基质局部积聚。我们认为,随着CC口出现更多不可逆疝,流出道功能将逐渐降低,IOP将升高。支持这一假设的关键数据来自临床研究,表明注射到POAG眼睛SC中的荧光素或台盼蓝的流动在某些区域被阻止进入巩膜外静脉。POAG患者非穿透性青光眼手术后预后较差似乎与这些阻塞的数量增加有关。我们的目标是确定我们已经确定的POAG眼中的不可逆疝是否可以解释临床上观察到的POAG患者中荧光素或台盼蓝从SC进入巩膜外静脉的阻塞,以及这些发现在POAG发病机制和非穿透性青光眼手术预后中的生理意义。我们假设POAG眼的流出道功能降低与前小管结缔组织和SC内壁的有效滤过面积减少相关,并与CC口不可逆疝入数量增加成比例相关。我们假设这些疝是临床研究中阻止荧光素或台盼蓝从SC进入巩膜外静脉的原因。为了研究这一假设,提出了三个具体的目标:1。区分急性IOP升高的正常人眼中观察到的可逆性疝入CC口与POAG眼中观察到的不可逆性疝入CC口之间的流体动力学和结构差异。2.确定临床观察到的从SC进入巩膜外静脉的台盼蓝或荧光素的阻塞是否是由与正常眼相比的青光眼眼的不可逆疝引起的。这将通过在自然发生的和激光诱导的青光眼猴眼中体内注射后追踪纳米颗粒穿过这些突出区域进行组织学检查。3.建立染料从SC到巩膜上静脉的流出模式,就像正常眼睛中出现的那样,称为“通道造影术”,并研究接受非穿透性青光眼手术的POAG患者的常见变化及其与术后IOP降低的关系。如果我们能证实不可逆的疝入CC口确实是阻塞房水流出的部位,那么将确定POAG中增加阻力的新部位。公共卫生关系:原发性开角型青光眼是永久性失明的主要原因,在40岁以上的个体中发现约2%,并且影响世界上超过7000万人。我们的研究目的是确定导致原发性开角型青光眼流出道阻力升高的病理因素。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Development of a novel two color tracer perfusion technique for the hydrodynamic study of aqueous outflow in bovine eyes.
开发一种新型双色示踪剂灌注技术,用于牛眼房水流出的流体动力学研究。
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    6.1
  • 作者:
    Zhu,Jing-yin;Ye,Wen;Gong,Hai-yan
  • 通讯作者:
    Gong,Hai-yan
Soluble Guanylate Cyclase a1-Deficient Mice: a novel murine model for Primary Open Angle Glaucoma.
可溶性鸟苷酸环化酶 a1 缺陷小鼠:一种新的原发性开角型青光眼小鼠模型。
  • DOI:
    10.5214/ans.0972.7531.200207
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    1.5
  • 作者:
    Buys,EmmanuelS;Ko,Yu-Chieh;Alt,Clemens;Hayton,SarahR;Jones,Alexander;Tainsh,LaurelT;Ren,Ruiyi;Giani,Andrea;Clerte',Maeva;Abernathy,Emma;Tainsh,RobertET;Oh,Dong-Jin;Malhotra,Rajeev;Arora,Pankaj;deWaard,Nadine;Yu,Binglan
  • 通讯作者:
    Yu,Binglan
Reversible changes in aqueous outflow facility, hydrodynamics, and morphology following acute intraocular pressure variation in bovine eyes.
牛眼急性眼压变化后房水流出设施、流体动力学和形态的可逆变化。
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    6.1
  • 作者:
    Zhu,Jing-ying;Ye,Wen;Wang,Ti;Gong,Hai-yan
  • 通讯作者:
    Gong,Hai-yan
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HAIYAN GONG其他文献

HAIYAN GONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HAIYAN GONG', 18)}}的其他基金

Function of Glycocalyx in the Trabecular Outflow Pathway
糖萼在小梁流出通路中的功能
  • 批准号:
    10170361
  • 财政年份:
    2020
  • 资助金额:
    $ 20.31万
  • 项目类别:
Cellular Physiology of the Aqueous Outflow Pathway
房水流出途径的细胞生理学
  • 批准号:
    8723227
  • 财政年份:
    2012
  • 资助金额:
    $ 20.31万
  • 项目类别:
Cellular Physiology of the Aqueous Outflow Pathway
房水流出途径的细胞生理学
  • 批准号:
    8549256
  • 财政年份:
    2012
  • 资助金额:
    $ 20.31万
  • 项目类别:
Cellular Physiology of the Aqueous Outflow Pathway
房水流出途径的细胞生理学
  • 批准号:
    8911320
  • 财政年份:
    2012
  • 资助金额:
    $ 20.31万
  • 项目类别:
Cellular Physiology of the Aqueous Outflow Pathway
房水流出途径的细胞生理学
  • 批准号:
    8343543
  • 财政年份:
    2012
  • 资助金额:
    $ 20.31万
  • 项目类别:
Cellular Physiology of the Aqueous Outflow Pathway
房水流出途径的细胞生理学
  • 批准号:
    9383966
  • 财政年份:
    2012
  • 资助金额:
    $ 20.31万
  • 项目类别:
Cellular Physiology of the Aqueous Outflow Pathway
房水流出途径的细胞生理学
  • 批准号:
    9144399
  • 财政年份:
    2012
  • 资助金额:
    $ 20.31万
  • 项目类别:
A Previously Unrecognized Site of Resistance in POAG
POAG 中以前未被识别的耐药位点
  • 批准号:
    7660602
  • 财政年份:
    2009
  • 资助金额:
    $ 20.31万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了